1. Home
  2. IPSC vs BDL Comparison

IPSC vs BDL Comparison

Compare IPSC & BDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • BDL
  • Stock Information
  • Founded
  • IPSC 2019
  • BDL 1959
  • Country
  • IPSC United States
  • BDL United States
  • Employees
  • IPSC N/A
  • BDL N/A
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • BDL Restaurants
  • Sector
  • IPSC Health Care
  • BDL Consumer Discretionary
  • Exchange
  • IPSC Nasdaq
  • BDL Nasdaq
  • Market Cap
  • IPSC 45.4M
  • BDL 52.7M
  • IPO Year
  • IPSC 2021
  • BDL N/A
  • Fundamental
  • Price
  • IPSC $0.55
  • BDL $32.00
  • Analyst Decision
  • IPSC Strong Buy
  • BDL
  • Analyst Count
  • IPSC 6
  • BDL 0
  • Target Price
  • IPSC $3.00
  • BDL N/A
  • AVG Volume (30 Days)
  • IPSC 1.5M
  • BDL 705.0
  • Earning Date
  • IPSC 11-13-2025
  • BDL 12-26-2025
  • Dividend Yield
  • IPSC N/A
  • BDL 1.72%
  • EPS Growth
  • IPSC N/A
  • BDL 41.91
  • EPS
  • IPSC N/A
  • BDL 2.32
  • Revenue
  • IPSC $113,337,000.00
  • BDL $201,851,000.00
  • Revenue This Year
  • IPSC $1,589.94
  • BDL N/A
  • Revenue Next Year
  • IPSC N/A
  • BDL N/A
  • P/E Ratio
  • IPSC N/A
  • BDL $13.76
  • Revenue Growth
  • IPSC 4122.69
  • BDL 8.84
  • 52 Week Low
  • IPSC $0.34
  • BDL $22.61
  • 52 Week High
  • IPSC $1.83
  • BDL $35.98
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 52.98
  • BDL 51.92
  • Support Level
  • IPSC $0.46
  • BDL $29.99
  • Resistance Level
  • IPSC $0.56
  • BDL $32.30
  • Average True Range (ATR)
  • IPSC 0.04
  • BDL 0.26
  • MACD
  • IPSC 0.00
  • BDL 0.06
  • Stochastic Oscillator
  • IPSC 76.21
  • BDL 75.63

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

About BDL Flanigan's Enterprises Inc.

Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.

Share on Social Networks: